Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...
Live Science on MSN4d
How does rowing affect your heart, and is it different to running?Rowing machines and treadmills do not challenge your cardiovascular system in the same way, so what is the science behind it?
Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...
Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...
Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...
Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.
News-Medical.Net on MSN3d
Study explores impact of severe tricuspid regurgitation in AFMR patientsAtrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback